These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12654544)

  • 1. Pharmaceutical profiling in drug discovery.
    Kerns EH; Di L
    Drug Discov Today; 2003 Apr; 8(7):316-23. PubMed ID: 12654544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate pharmaceutical profiling for drug discovery.
    Kerns EH; Di L
    Curr Top Med Chem; 2002 Jan; 2(1):87-98. PubMed ID: 11899067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-like property concepts in pharmaceutical design.
    Di L; Kerns EH; Carter GT
    Curr Pharm Des; 2009; 15(19):2184-94. PubMed ID: 19601822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling drug-like properties in discovery research.
    Di L; Kerns EH
    Curr Opin Chem Biol; 2003 Jun; 7(3):402-8. PubMed ID: 12826129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational methods to estimate drug development parameters.
    Podlogar BL; Muegge I; Brice LJ
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):102-9. PubMed ID: 11727315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling for ADME.
    Guner OF; Bowen JP
    Curr Top Med Chem; 2013; 13(11):1327-42. PubMed ID: 23675939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
    DeWitte RS; Robins RH
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity measures for rational set selection and analysis of combinatorial libraries: the Diverse Property-Derived (DPD) approach.
    Lewis RA; Mason JS; McLay IM
    J Chem Inf Comput Sci; 1997; 37(3):599-614. PubMed ID: 9177003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs as materials: valuing physical form in drug discovery.
    Gardner CR; Walsh CT; Almarsson O
    Nat Rev Drug Discov; 2004 Nov; 3(11):926-34. PubMed ID: 15520815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of physiochemical property profiles of development and marketed oral drugs.
    Wenlock MC; Austin RP; Barton P; Davis AM; Leeson PD
    J Med Chem; 2003 Mar; 46(7):1250-6. PubMed ID: 12646035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmental methods in the analysis of biological activities of diverse compound sets.
    Japertas P; Didziapetris R; Petrauskas A
    Mini Rev Med Chem; 2003 Dec; 3(8):797-808. PubMed ID: 14529499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High throughput screening of pharmacokinetics and metabolism in drug discovery (I)--establishment of assessment system for absorption to compounds with a wide diversity of physical properties].
    Komura H; Kawahara I; Shigemoto Y; Matsuda K; Ano R; Murayama Y; Moriwaki T; Yoshida NH
    Yakugaku Zasshi; 2005 Jan; 125(1):121-30. PubMed ID: 15635283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection.
    Theil FP; Guentert TW; Haddad S; Poulin P
    Toxicol Lett; 2003 Feb; 138(1-2):29-49. PubMed ID: 12559691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.